Form 4: Verastem Director Acquires 36,000 RSUs

Verastem, Inc. reports that Director Brian M. Stuglik was granted 36,000 Restricted Stock Units (RSUs) on May 21, 2026.

Summary

• Brian M. Stuglik, a Director at Verastem, Inc., received a grant of 36,000 Restricted Stock Units (RSUs) on May 21, 2026.
• These RSUs are part of the Issuer's Amended and Restated 2021 Equity Incentive Plan.
• Each RSU represents the contingent right to receive one share of Verastem's Common Stock.
• The RSUs will vest in twelve substantially equal installments, with the first eleven installments vesting monthly from June 2026 to April 2027.
• The final installment vests on the earlier of the day before the 2027 Annual Meeting of Stockholders or May 31, 2027.
• Vesting is contingent upon Mr. Stuglik continuing to serve as a director on each respective vesting date.
• Following this transaction, Mr. Stuglik beneficially owns 137,147 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard equity grant to a director rather than a significant financial event or strategic shift.

Positives

• Director Brian M. Stuglik's acquisition of 36,000 RSUs indicates continued commitment and alignment with the company's long-term performance.
• The grant is structured with vesting tied to continued service, incentivizing ongoing director engagement.

Risks

• The value of the RSUs is subject to the future performance of Verastem's Common Stock.
• Vesting is contingent on continued service, meaning any departure before vesting dates would result in forfeiture of unvested units.

Future Outlook

The RSUs are scheduled to vest over a period extending through May 2027, contingent on continued service as a director.

Industry Context

StockSavvy.ai notes that grants of Restricted Stock Units (RSUs) to directors are a common practice in the biotechnology and pharmaceutical sectors, aligning executive and director interests with shareholder value creation through long-term equity incentives.

Stakeholder Impact

• Shareholders: The grant reinforces director alignment with shareholder interests, potentially positively impacting long-term value.
• Employees: The equity incentive plan structure may set a precedent for other employee compensation.
• Management: Demonstrates a commitment to retaining key leadership through performance-based incentives.

Next Steps

• Vesting of RSU installments according to the schedule outlined.
• Continued service by Brian M. Stuglik as a director of Verastem, Inc.

Key Dates

Keywords

Verastem, VSTM, Form 4, Insider Transaction, Restricted Stock Units, RSUs, Equity Incentive Plan, Director Compensation, Beneficial Ownership, Stock Vesting